Search | MIT Sloan

MIT Sloan logo

Smart. Open. Grounded. Inventive. Explore our most recent Ideas.

contact

MBA

Through intellectual rigor and experiential learning, this full-time, two-year MBA program develops leaders who make a difference in the world.

Leaders for Global Operations

Earn your MBA and SM in engineering with this transformative two-year program.

Master of Finance

A rigorous, hands-on program that prepares adaptive problem solvers for premier finance careers.

Master of Business Analytics

A 12-month program focused on applying the tools of modern data science, optimization and machine learning to solve real-world business problems.

Master of Science in Management Studies

Combine an international MBA with a deep dive into management science. A special opportunity for partner and affiliate schools only.

PhD

A doctoral program that produces outstanding scholars who are leading in their fields of research.

Undergraduate

Bring a business perspective to your technical and quantitative expertise with a bachelor’s degree in management, business analytics, or finance.

MBA Early (Deferred admissions option)

Apply now and work for two to five years. We'll save you a seat in our MBA class when you're ready to come back to campus for your degree.

Executive Programs

MIT Executive MBA

The 20-month program teaches the science of management to mid-career leaders who want to move from success to significance.

MIT Sloan Fellows MBA

A full-time MBA program for mid-career leaders eager to dedicate one year of discovery for a lifetime of impact.

System Design & Management

A joint program for mid-career professionals that integrates engineering and systems thinking. Earn your master’s degree in engineering and management.

Executive Education

Non-degree programs for senior executives and high-potential managers.

Visiting Fellows

A non-degree, customizable program for mid-career professionals.

191 - 200 out of 1292

MIT Sloan Health Systems Initiative

HSI Fall 2021 Research Updates

HSI Fall 2021 Research Updates

Learn More

MIT Sloan Health Systems Initiative

Focus on Roles and Status, Not Just Tech, When Implementing

Professor Kate Kellogg’s recent healthcare research uncovers crucial considerations for successful technology change including challenges to employees’ roles and status through detailed case analyses.

Learn More

MIT Sloan Health Systems Initiative

Prize-winning Research Reduces Transportation Inefficiencies

Research by Jónas Jónasson and PhD student Emma Gibson’s shows practical ways to speed up medical sample transportation in Malawi.

Learn More

MIT Sloan Health Systems Initiative

HSI Spring 2021 Research Updates

See progress on HSI-funded research by Jonas Jonasson, Nikos Trichakis, Georgia Perakis, Erin Kelly, and Catherine Tucker

Learn More

MIT Sloan Health Systems Initiative

Healthcare Certificate Grads Make Their Mark

Short bios of Healthcare Certificate graduates

Learn More

MIT Sloan Health Systems Initiative

Healthcare Lab at MGH Video

Massachusetts General Hospital in Boston serves as a host to a team of 4 MIT Sloan graduate students working to improve the efficiency of the pathology department's processes.

Learn More

MIT Sloan Health Systems Initiative

Food Systems Innovator Highlights Urgent and Complex Challenges

HSI seminar with Katie Stebbins

Learn More

MIT Sloan Health Systems Initiative

Candice Hinds, Sloan Fellow '23, Reflects on Her Time at Sloan

Candice Hinds, Sloan Fellow ’23, Healthcare Grad discusses her Sloan School experience.

Learn More

MIT Sloan Health Systems Initiative

Delfi Krishna: How to Compete in the Gene Therapy Market

Cell and gene therapies represent an exciting and complex new treatment type, with the potential to treat a vast range of indications.

Learn More

Press

New statistical approach to COVID-19 clinical trials aims to accelerate drug approval process and attract more funding

By

MIT Sloan Office of Communications

The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.

May 18, 2020

Read Article